140 related articles for article (PubMed ID: 18383318)
1. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
Landburg PP; Teerlink T; Muskiet FA; Duits AJ; Schnog JJ;
Am J Hematol; 2008 Jul; 83(7):577-9. PubMed ID: 18383318
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.
Schnog JB; Teerlink T; van der Dijs FP; Duits AJ; Muskiet FA;
Ann Hematol; 2005 May; 84(5):282-6. PubMed ID: 15599544
[TBL] [Abstract][Full Text] [Related]
3. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Kato GJ; Wang Z; Machado RF; Blackwelder WC; Taylor JG; Hazen SL
Br J Haematol; 2009 May; 145(4):506-13. PubMed ID: 19344390
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia.
Lücke T; Tsikas D; Kanzelmeyer N; Vaske B; Das AM
Metabolism; 2006 Dec; 55(12):1599-603. PubMed ID: 17142130
[TBL] [Abstract][Full Text] [Related]
5. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
Schulze F; Maas R; Freese R; Schwedhelm E; Silberhorn E; Böger RH
Eur J Clin Invest; 2005 Oct; 35(10):622-6. PubMed ID: 16178881
[TBL] [Abstract][Full Text] [Related]
6. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
Landburg PP; Teerlink T; Biemond BJ; Brandjes DP; Muskiet FA; Duits AJ; Schnog JB;
Blood Cells Mol Dis; 2010 Apr; 44(4):229-32. PubMed ID: 20185345
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
Xiong Y; Lei M; Fu S; Fu Y
Life Sci; 2005 May; 77(2):149-59. PubMed ID: 15862600
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
[TBL] [Abstract][Full Text] [Related]
12. Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.
Krzyzanowska K; Mittermayer F; Schnack C; Hofer M; Wolzt M; Schernthaner G
Eur J Clin Invest; 2005 Mar; 35(3):208-13. PubMed ID: 15733076
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
[TBL] [Abstract][Full Text] [Related]
14. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
15. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation.
Maeda T; Yoshimura T; Okamura H
J Soc Gynecol Investig; 2003 Jan; 10(1):2-4. PubMed ID: 12517586
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Yoo JH; Lee SC
Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
[TBL] [Abstract][Full Text] [Related]
18. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC.
Teerlink T
Methods Mol Med; 2005; 108():263-74. PubMed ID: 16028689
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
Kielstein JT; Impraim B; Simmel S; Bode-Böger SM; Tsikas D; Frölich JC; Hoeper MM; Haller H; Fliser D
Circulation; 2004 Jan; 109(2):172-7. PubMed ID: 14662708
[TBL] [Abstract][Full Text] [Related]
20. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Antwi-Boasiako C; Campbell AD
Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
